Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: The diamond Study

Gut

Volumn 59, Issue 6, 2010, Pages 714-721

  Dent, John ^a   Vakil, Nimish ^b   Jones, Roger ^c   Bytzer, Peter ^d   Schöning, Uwe ^e   Halling, Katarina ^f   Junghard, Ola ^g   Lind, Tore ^g  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d University of Køge   (Denmark)

^e ASTRAZENECA   (United Kingdom)

^f PRO Consulting   (Sweden)

^g ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENDOSCOPY; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; GENERAL PRACTITIONER; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT MONITORING; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-ULCER AGENTS; CHILD; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROTON PUMP INHIBITORS; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 77953704839     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.200063     Document Type: Article

References (24)

1. Shaheen NJ, Hansen RA, Morgan DR, et al. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol 2006;101:2128-38.
2. Dent J, El-Serag HB, Wallander M-A, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710-17.
3. Tytgat GN, McColl K, Tack J, et al. New algorithm for the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2008;27:249-56.
4. Kahrilas PJ, Shaheen NJ, Vaezi MF. American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology 2008;135:1392-413.
5. Vakil N, van Zanten S, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-20.
6. Shaw MJ, Talley NJ, Beebe TJ, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001;96:52-7.
7. Numans ME, Lau J, de Wit NJ, et al. Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease. Ann Intern Med 2004;140:518-27.
8. American Gastroenterological Association. American Gastroenterological Association medical position statement: guidelines on the use of esophageal pH recording. Gastroenterology 1996;110:1981.
9. Pandolfino JE, Richter JE, Ours T, et al. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 2003;98:740-9. (Pubitemid 36576296)
10. Weusten BLAM, Roelofs JMM, Akkermans LMA, et al. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994;107:1741-5.
11. Svedlund J, Sjödin I, Dotevall G. GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33:129-34. (Pubitemid 18054672)
12. Malfertheiner P, Enrique Domínguez-Muñoz J, Heckenmüller H, et al. Modified rapid urease test for detection of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1996;8:53-6. (Pubitemid 26093597)
13. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-80. (Pubitemid 29333764)
14. Talley NJ, Stanghellini V, Heading RC, et al. Functional gastroduodenal disorders. Gut 1999;45(Suppl II):II37-42.
15. Thomson ABR, Barkun AN, Armstrong D, et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment-Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther 2003;17:1481-91. Corrigenda in: Aliment Pharmacol Ther 2004;20:702.
16. Jones R, Coyne K, Wiklund I. The gastro-oesophageal Reflux Disease Impact Scale: a patient management tool for primary care. Aliment Pharmacol Ther 2007;25:1451-59.
17. Stanghellini V, Armstrong D, Mönnikes H, et al. Systematic review: do we need a new gastro-oesophageal reflux disease questionnaire? Digestion 2007;75(Suppl 1):3-16.
18. Holloway RH. Questionnaires in gastroesophageal reflux disease: what do the answers mean? J Gastroenterol Hepatol 2009;24:1311-12.
19. Jones R, Junghard O, Dent J, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther 2009;30:1030-8.
20. Brotherton SE, Rockey PH, Etzel SI. US graduate medical education, 2004-2005: trends in primary care specialties. JAMA 2005;294:1075-82.
21. van Zanten SV, Flook N, Talley NJ, et al. One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study. Aliment Pharmacol Ther 2007;26:665-72.
22. Talley NJ, Vakil N, Lauritsen K, et al. Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response? Aliment Pharmacol Ther 2007;26:673-82.
23. Khan M, Santana J, Donnellan C, et al. Medical treatments in the short term management of reflux oesophagitis. Cochrane Database Syst Rev 2007;(2):CD003244.
24. Tack J, Caenepeel P, Arts J, et al. Prevalence of acid reflux in functional dyspepsia and its association with symptom profile. Gut 2005;54:1370-6.